Tuana B S, Murphy B J, Yi Q
Department of pharmacology, Faculty of Medicine, University of Toronto, Canada.
Mol Cell Biochem. 1988 Mar-Apr;80(1-2):133-43. doi: 10.1007/BF00231011.
Tritiated analogues of the Ca2+ channel blockers such as [3H] PN200-110, [3H] verapamil and [3H] diltiazem have been used to identify and isolate Ca2+ antagonist receptors. The Ca2+ antagonist binding sites were solubilized from skeletal muscle transverse tubules with the detergent CHAPS and purified by wheat germ lectin column chromatography and sucrose density gradient centrifugation. The isolated proteins retained their ability to bind the various classes of Ca2+ channel blockers. Polypeptides of 170, 150, 108, 56, and 32 kDa were found to be present in the purified receptor fraction when analysed by sodium dodecyl sulfate polyacrylamide gel electrophoresis under non-reducing conditions. The apparent molecular weight of the 170 kDa polypeptide changed to 145 kDa in the presence of reducing agents, as where the apparent molecular weight of the 150, 108, 56 and 32 kDa peptides remained unchanged. An endogenous protein-kinase present in the original membranes, co-purified with the receptor and stimulated the phosphorylation of the 150 and 56 kDa polypeptides in the isolated fraction.
钙通道阻滞剂的氚代类似物,如[3H]PN200 - 110、[3H]维拉帕米和[3H]地尔硫䓬,已被用于鉴定和分离钙拮抗剂受体。钙拮抗剂结合位点用去污剂CHAPS从骨骼肌横管中溶解出来,并通过麦胚凝集素柱色谱和蔗糖密度梯度离心进行纯化。分离出的蛋白质保留了其结合各类钙通道阻滞剂的能力。在非还原条件下通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳分析时,发现纯化的受体组分中存在170、150、108、56和32 kDa的多肽。在还原剂存在的情况下,170 kDa多肽的表观分子量变为145 kDa,而150、108、56和32 kDa肽的表观分子量保持不变。原始膜中存在的一种内源性蛋白激酶与受体共同纯化,并刺激分离组分中150和56 kDa多肽的磷酸化。